hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Doctors Without Borders criticises Johnson & Johnson for not sharing HIV drug patents that would allow access for poor in developing countries

Get RSS feed of these results

All components of this story

Article
25 April 2011

Johnson & Johnson takes heat from Doctors Without Borders for not sharing HIV drug patents [USA]

Author: Susan Todd, Star Ledger [USA]

Doctors without Borders criticized Johnson & Johnson today for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries…"Johnson & Johnson…has chosen to turn its back on these patients’’ [said Sophie Delaunay, a spokeswoman for Doctors Without Borders]. In an e-mail today, the New Brunswick-based healthcare giant said it preferred to provide access to its compounds through agreements with generic manufacturers. One of its latest agreements was announced in February…

Read the full post here

Article
25 April 2011

Johnson & Johnson Turns Its Back on AIDS Patients: Pharma Giant’s Refusal to Participate in Patent Pool Undermines Access to Key AIDS Drugs

Author: Doctors Without Borders/Medicines Sans Frontieres

Pharmaceutical giant Johnson & Johnson is putting the lives of people living with HIV at stake by refusing to participate in the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today…

Read the full post here